Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
---|---|---|---|---|---|---|---|
Karuna Therapeutics, Inc. | Director | Common Stock | 6.56K | $2.08M | $316.81 | Jun 24, 2021 | Direct |
Karuna Therapeutics, Inc. | Director | Option (right to buy) | 8.5K | $785K | $92.30 | Jun 16, 2021 | Direct |
Aligos Therapeutics, Inc. | Director | Stock Option (Right to Buy) | 120K | Aug 7, 2024 | Direct | ||
Fusion Pharmaceuticals Inc. | Director | Stock Option (Right to Buy) | 17K | Jun 14, 2023 | Direct | ||
Akouos, Inc. | Director | Common Stock | 0 | $12.50 | Nov 30, 2022 | Direct | |
Akouos, Inc. | Director | Stock Option (right to buy) | 0 | Dec 1, 2022 | Direct |
Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
---|---|---|---|---|---|---|---|
ALGS | Aligos Therapeutics, Inc. | Aug 7, 2024 | 1 | $0 | 4 | Aug 9, 2024 | Director |
ALGS | Aligos Therapeutics, Inc. | Aug 7, 2024 | 0 | $0 | 3 | Aug 9, 2024 | Director |
FUSN | Fusion Pharmaceuticals Inc. | Jun 14, 2023 | 1 | $0 | 4 | Jun 14, 2023 | Director |
AKUS | Akouos, Inc. | Nov 30, 2022 | 2 | $0 | 4 | Dec 2, 2022 | Director |
AKUS | Akouos, Inc. | Jun 23, 2022 | 1 | $0 | 4 | Jun 27, 2022 | Director |
FUSN | Fusion Pharmaceuticals Inc. | Jun 14, 2022 | 1 | $0 | 4 | Jun 22, 2022 | Director |
KRTX | Karuna Therapeutics, Inc. | Jun 24, 2021 | 1 | $0 | 4 | Jun 28, 2021 | Director |
AKUS | Akouos, Inc. | Jun 24, 2021 | 1 | $0 | 4 | Jun 25, 2021 | Director |
KRTX | Karuna Therapeutics, Inc. | Jun 16, 2021 | 1 | $0 | 4 | Jun 23, 2021 | Director |
FUSN | Fusion Pharmaceuticals Inc. | Jun 4, 2021 | 1 | $0 | 4 | Jun 7, 2021 | Director |